FIELD: medicine.
SUBSTANCE: disclosed is a method of treating Sjogren's syndrome (SjS) in a subject in need thereof, comprising administering a daily dose of about 10 mg to approximately 200 mg of a compound of formula (I)
(I)
or a pharmaceutically acceptable salt thereof, where the term approximately indicates a deviation of ±10%.
EFFECT: invention provides treating Sjogren's syndrome with a compound of formula (I) in effective and safe doses.
16 cl, 7 dwg, 10 tbl, 3 ex
| Title |
Year |
Author |
Number |
| METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING BRUTON TYROSINE KINASE INHIBITOR |
2020 |
- Bhattacharya, Souvik
- Bieth, Bruno
- Cabanski, Maciej
- Cenni, Bruno
- De Buck, Stefan
- Kaul, Martin
- Kinhikar, Arvind
- Radivojevic, Andrijana
- Severin, Thomas
- Storim, Julian
- Vitaliti Garami, Alessandra
|
RU2818678C2 |
| LTA4H INHIBITORS FOR TREATING PURULENT HYDRADENITIS |
2020 |
- Loesche, Christian
- Penno, Carlos
- Roehn, Till
- Wieczorek, Grazyna
|
RU2821362C2 |
| COMPOSITIONS AND METHODS OF TREATMENT OR PREVENTION OF VASOMOTOR SYMPTOMS |
2018 |
|
RU2815402C2 |
| COMBINED TREATMENT OF ARTHRITIS |
2020 |
- Jonassen, Tomas, Engelbrekht, Nordkild
|
RU2828044C2 |
| ANTIBODIES TO CD40 FOR USE IN THE TREATMENT OF SJOGREN'S SYNDROME |
2018 |
- Espie, Pascal
- Gergely, Peter
- Rush, James
|
RU2790558C2 |
| METHODS OF TREATING DISEASES ASSOCIATED WITH S1P1 RECEPTOR |
2021 |
- Fung, Maple
- Selfridge, Andrew Christopher Wesley
- Ahluwalia, Gurpreet
|
RU2821032C1 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND APPLICATIONS THEREOF |
2017 |
- Colquhoun, Helen
- Kanes, Stephen, Jay
|
RU2766155C2 |
| TYROSINE KINASE INHIBITOR OR ITS PHARMACEUTICAL SALT FOR TREATMENT OF SYSTEMIC MASTOCYTOSIS |
2016 |
- Moussy, Alain
- Kinet, Jean-Pierre
|
RU2778337C2 |
| COMBINATION OF PI3 KINASE INHIBITOR WITH PACLITAXEL FOR USE IN TREATMENT OR PREVENTION OF HEAD AND NECK CANCER |
2014 |
- Khiravat Samit
- Massachezi Kristian
- Di Tomazo Emmanyuell
|
RU2672555C2 |
| USE OF A DERIVATIVE GLUTARIMIDE TO OVERCOME RESISTANCE TO STEROIDS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT SIGNALING OF INTERFERON GAMMA |
2018 |
- Nebolsin Vladimir Evgenevich
|
RU2712281C1 |
